About 6,870,000 results
FDA Approves Isatuximab/VRd in Transplant-Ineligible NDMM
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone …
Sarclisa Approved for Transplant-Ineligible Newly Diagnosed …
Newly diagnosed multiple myeloma: making sense of the menu
ASH 2023: Advances in Combination Therapy for Newly …
Sanofi's Sarclisa Secures FDA Approval For First-Line Multiple …
Daratumumab-based quadruplet therapy for transplant-eligible …
Real-World Outcomes of Newly Diagnosed Multiple Myeloma (NDMM…
Daratumumab plus RVd for newly diagnosed multiple myeloma: final ...
Phase 2 and 3 Transplant-Eligible NDMM Data Build Evidence for ...